MedPath

Transform Type 2: Examining Meal-Delivery and Education for Diabetes Self-Care

Not Applicable
Completed
Conditions
PreDiabetes
Diabetes Mellitus, Type 2
Interventions
Behavioral: Education
Behavioral: Meal delivery
Behavioral: Lifestyle coaching
Registration Number
NCT04810026
Lead Sponsor
UnitedHealth Group
Brief Summary

The purpose of this research is to understand the impact of medically tailored meals on health-related biometrics (e.g., glucose time-in-range, waist-hip ratio, cholesterol) and how providing medically tailored meals promotes engagement in diabetes education and drives information-seeking behavior.

Detailed Description

The purpose of this research is to understand the impact of medically tailored meals on health-related biometrics (e.g., glucose time-in-range, waist-hip ratio) and how providing medically tailored meals promotes engagement in diabetes education and drives information-seeking behavior. Secondary purposes are to characterize the relationship between information-seeking behaviors and glycemic control; to characterize the relationship between psychometric survey results and program engagement, biometrics, and information-seeking behaviors; and to understand how meal provision and materials influence program satisfaction and adherence to healthy diabetes-related behaviors.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
41
Inclusion Criteria
  • Be a patient, employee, or employee dependent at Utica Park Clinic in Oklahoma
  • Be diagnosed with type 2 diabetes, prediabetes, and/or have an A1c result of 5.7 percent or above
  • Be above an ideal weight (for example, body mass index [BMI] greater than or equal to 25)
  • 18 years of age or older
  • Have UnitedHealthcare insurance for 1 year+
  • Have an active e-mail address
  • Have a smartphone with access to the internet that is compatible with the Dexcom G6 app
Exclusion Criteria
  • Be undergoing any form of cancer treatment
  • Be pregnant or breastfeeding
  • Have allergies to nightshade vegetable (e.g., bell peppers, potatoes, tomatoes) or legumes (e.g., green beans, peas), or tree nuts
  • Currently taking anti-psychotic medications to control schizophrenia and bipolar disorders, as well as other mental disorders including dementia, major depression, and even drug addiction
  • Be currently taking insulin
  • Be currently taking sulfonylureas

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group 2: Education and MealsMeal deliveryMeal delivery (3 meals per day, 5 days per week) for 12 weeks, push notifications for online diabetes self-management education for 12 weeks, passive access to lifestyle education for 16 weeks
Group 3: Education, Meals, CoachingMeal deliveryMeal delivery (3 meals per day, 5 days per week) for 12 weeks, coaching program (e.g., diabetes-specific coaching and education, push notifications for lifestyle education modules, community support) for 12 weeks, and passive access to lifestyle education for final 4 weeks
Group 2: Education and MealsEducationMeal delivery (3 meals per day, 5 days per week) for 12 weeks, push notifications for online diabetes self-management education for 12 weeks, passive access to lifestyle education for 16 weeks
Group 3: Education, Meals, CoachingLifestyle coachingMeal delivery (3 meals per day, 5 days per week) for 12 weeks, coaching program (e.g., diabetes-specific coaching and education, push notifications for lifestyle education modules, community support) for 12 weeks, and passive access to lifestyle education for final 4 weeks
Group 1: Education onlyEducationPush notifications for online diabetes self-management education for 12 weeks, passive access to lifestyle education for 16 weeks
Group 3: Education, Meals, CoachingEducationMeal delivery (3 meals per day, 5 days per week) for 12 weeks, coaching program (e.g., diabetes-specific coaching and education, push notifications for lifestyle education modules, community support) for 12 weeks, and passive access to lifestyle education for final 4 weeks
Primary Outcome Measures
NameTimeMethod
Change in mean glucose time in range from baseline at Week 12Week 0 and Week 12

Percentage of time estimated glucose value (EGV) from CGM is between 70 mg/dL and 180 mg/dL, measured daily with weekly composite results

Change in mean glucose time in range from baseline at Week 6Week 0 and Week 6

Percentage of time estimated glucose value (EGV) from continuous glucose monitor (CGM) is between 70 mg/dL and 180 mg/dL, measured daily with weekly composite results

Change in mean glucose time in range from baseline at Week 16Week 0 and Week 16

Percentage of time estimated glucose value (EGV) from CGM is between 70 mg/dL and 180 mg/dL, measured daily with weekly composite results

Secondary Outcome Measures
NameTimeMethod
Change in self-reported waist-to-hip ratioWeekly, Weeks 0-12

waist circumference, hip circumference, self-reported weekly; calculated by dividing the waist circumference by the hip circumference

Change in blood test results from baselineWeek 0, Week 12

Difference in measurements of HbA1c, HDL cholesterol, total cholesterol, LDL cholesterol, triglycerides, and high-sensitivity C-reactive protein (hs-CRP) obtained from blood tests

Change in CGM-derived glucose features from baselineWeek 0, Week 6, Week 12, and Week 16

Average of EGVs, percentage time above and below range (\< 70 mg/dL or \>180 mg/dL), and glucose variability (standard deviation of EGVs), measured via daily with weekly composite results

Change in self-reported blood pressureWeekly, Weeks 0-12

blood pressure, self-reported weekly

Trial Locations

Locations (1)

OptumLabs

🇺🇸

Minnetonka, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath